Key Points
-
The nuclear factor of activated T cells (NFAT) family of transcription factors consists of five members, NFAT1âNFAT5, which share a conserved DNA-binding domain that is structurally related to the REL-homology domain of REL and nuclear factor-κB family members.
-
T cells express three of the four calcium-regulated NFAT proteins: NFAT1, NFAT2 and NFAT4. These proteins are key regulators of T-cell activation, differentiation and development.
-
In T cells, NFAT proteins are activated following T-cell receptor (TCR) ligation. Increases in calcium that are induced by TCR engagement activate calcineurin, which causes NFAT dephosphorylation and nuclear translocation.
-
Several kinases, including casein kinase 1 (CK1) and glycogen-synthase kinase 3 (GSK3), are also involved in the regulation of NFAT nuclear import and export.
-
In activated T cells, NFAT proteins synergize with activator protein 1 (AP1) transcription factors at composite sites that are located in the promoters and enhancers of many cytokine genes.
-
Interactions of NFAT proteins with transcription factors other than AP1 have been described for different gene promoters in T cells and can induce the activation or inhibition of NFAT activity. NFAT1 can also bind as a homodimer to NF-κB-binding motifs.
-
The results obtained from the analysis of single and double gene-knockout mice indicate that, although there is a certain level of redundancy in the NFAT family of transcription factors, some specific T-cell functions might be regulated by specific NFAT proteins.
-
Experimental evidence indicates that, during T-cell development, calciumâcalcineurinâNFAT signalling is a key regulator of positive selection. NFAT2 and NFAT4 might also control thymocyte proliferation and survival.
-
NFAT proteins cooperate with lineage-specific transcription factors to determine pathways of T helper (TH)-cell differentiation into TH1- or TH2-cell populations.
-
Programmes of gene expression that lead to T-cell inactivation and are crucial to maintain T-cell tolerance are also regulated by NFAT proteins in the absence of AP1 cooperation.
-
Disrupting function-specific NFAT interactions with other transcription factors might provide new targets for the development of more specific therapeutic approaches to control immune responses during autoimmunity or graft rejection.
Abstract
Since the discovery of the first nuclear factor of activated T cells (NFAT) protein more than a decade ago, the NFAT family of transcription factors has grown to include five members. It has also become clear that NFAT proteins have crucial roles in the development and function of the immune system. In T cells, NFAT proteins not only regulate activation but also are involved in the control of thymocyte development, T-cell differentiation and self-tolerance. The functional versatility of NFAT proteins can be explained by their complex mechanism of regulation and their ability to integrate calcium signalling with other signalling pathways. This Review focuses on the recent advances in our understanding of the regulation, mechanism of action and functions of NFAT proteins in T cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
209,00 ⬠per year
only 17,42 ⬠per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Shaw, J. P. et al. Identification of a putative regulator of early T cell activation genes. Science 241, 202â205 (1988).
Rao, A., Luo, C. & Hogan, P. G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707â747 (1997).
Hogan, P. G., Chen, L., Nardone, J. & Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205â2232 (2003).
Graef, I. A., Chen, F. & Crabtree, G. R. NFAT signaling in vertebrate development. Curr. Opin. Genet. Dev. 11, 505â512 (2001).
Crabtree, G. R. & Olson, E. N. NFAT signaling: choreographing the social lives of cells. Cell 109, S67âS79 (2002). References 3 and 5 provide an excellent overview of the regulation of NFAT proteins and their function in different organs and tissues.
Kiani, A. et al. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation. J. Leukoc. Biol. 76, 1057â1065 (2004).
Lopez-Rodriguez, C., Aramburu, J., Rakeman, A. S. & Rao, A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl Acad. Sci. USA 96, 7214â7219 (1999).
Miyakawa, H., Woo, S. K., Dahl, S. C., Handler, J. S. & Kwon, H. M. Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl Acad. Sci. USA 96, 2538â2542 (1999).
Stroud, J. C., Lopez-Rodriguez, C., Rao, A. & Chen, L. Structure of a TonEBPâDNA complex reveals DNA encircled by a transcription factor. Nature Struct. Biol. 9, 90â94 (2002).
Lopez-Rodriguez, C. et al. Bridging the NFAT and NF-κB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity 15, 47â58 (2001).
Go, W. Y., Liu, X., Roti, M. A., Liu, F. & Ho, S. N. NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc. Natl Acad. Sci. USA 101, 10673â10678 (2004).
Luo, C. et al. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol. Cell. Biol. 16, 3955â3966 (1996).
Imamura, R. et al. Carboxyl-terminal 15-amino acid sequence of NFATx1 is possibly created by tissue-specific splicing and is essential for transactivation activity in T cells. J. Immunol. 161, 3455â3463 (1998).
Park, J., Takeuchi, A. & Sharma, S. Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc. J. Biol. Chem. 271, 20914â20921 (1996).
Chuvpilo, S. et al. Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J. Immunol. 162, 7294â7301 (1999).
Chen, L., Glover, J. N., Hogan, P. G., Rao, A. & Harrison, S. C. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392, 42â48 (1998).
Feske, S., Okamura, H., Hogan, P. G. & Rao, A. Ca2+/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun. 311, 1117â1132 (2003).
Garcia-Cozar, F. J. et al. Two-site interaction of nuclear factor of activated T cells with activated calcineurin. J. Biol. Chem. 273, 23877â23883 (1998).
Aramburu, J. et al. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol. Cell 1, 627â637 (1998).
Aramburu, J. et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285, 2129â2133 (1999). This paper describes the identification of a selective peptide that can specifically inhibit NFATâcalcineurin interactions and block cytokine expression by T cells.
Li, H., Rao, A. & Hogan, P. G. Structural delineation of the calcineurinâNFAT interaction and its parallels to PP1 targeting interactions. J. Mol. Biol. 342, 1659â1674 (2004).
Liu, J., Masuda, E. S., Tsuruta, L., Arai, N. & Arai, K. Two independent calcineurin-binding regions in the N-terminal domain of murine NF-ATx1 recruit calcineurin to murine NF-ATx1. J. Immunol. 162, 4755â4761 (1999).
Park, S., Uesugi, M. & Verdine, G. L. A second calcineurin binding site on the NFAT regulatory domain. Proc. Natl Acad. Sci. USA 97, 7130â7135 (2000).
Liu, J., Arai, K. & Arai, N. Inhibition of NFATx activation by an oligopeptide: disrupting the interaction of NFATx with calcineurin. J. Immunol. 167, 2677â2687 (2001).
Coghlan, V. M. et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267, 108â111 (1995).
Sun, L. et al. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 8, 703â711 (1998).
Kashishian, A. et al. AKAP79 inhibits calcineurin through a site distinct from the immunophilin-binding region. J. Biol. Chem. 273, 27412â27419 (1998).
Klauck, T. M. et al. Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 271, 1589â1592 (1996).
Rothermel, B. et al. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J. Biol. Chem. 275, 8719â8725 (2000).
Esau, C. et al. Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells. J. Exp. Med. 194, 1449â1459 (2001).
Ryeom, S., Greenwald, R. J., Sharpe, A. H. & McKeon, F. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nature Immunol. 4, 874â881 (2003).
Okamura, H. et al. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 6, 539â550 (2000). This study describes the mechanism of NFAT1 activation by the concerted dephosphorylation of several serines, which induce a conformational switch that exposes a nuclear-localization signal.
Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P. & Crabtree, G. R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275, 1930â1934 (1997).
Chow, C. W., Rincon, M., Cavanagh, J., Dickens, M. & Davis, R. J. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 278, 1638â1641 (1997).
Chow, C. W., Dong, C., Flavell, R. A. & Davis, R. J. c-Jun NH2-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol. Cell. Biol. 20, 5227â5234 (2000).
Okamura, H. et al. A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol. Cell. Biol. 24, 4184â4195 (2004).
Gomez del Arco, P., Martinez-Martinez, S., Maldonado, J. L., Ortega-Perez, I. & Redondo, J. M. A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp. J. Biol. Chem. 275, 13872â13878 (2000).
Zhu, J. et al. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 93, 851â861 (1998). References 33, 36 and 38 identify GSK3 and CK1 as NFAT kinases that regulate nuclear import and/or export of NFAT proteins.
Yang, T. T., Xiong, Q., Enslen, H., Davis, R. J. & Chow, C. W. Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol. Cell. Biol. 22, 3892â3904 (2002).
Beals, C. R., Clipstone, N. A., Ho, S. N. & Crabtree, G. R. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev. 11, 824â834 (1997).
Chuvpilo, S. et al. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10, 261â269 (1999).
Zhou, B. et al. Regulation of the murine Nfatc1 gene by NFATc2. J. Biol. Chem. 277, 10704â10711 (2002).
Macian, F. et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719â731 (2002). This study shows that, in the absence of AP1, calciumâcalcineurinâNFAT signals control the activation of a programme of gene expression that induces T-cell inactivation.
Barlic, J. et al. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms. J. Biol. Chem. 279, 48520â48534 (2004).
Diehl, S. et al. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J. Exp. Med. 196, 39â49 (2002).
Terui, Y., Saad, N., Jia, S., McKeon, F. & Yuan, J. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1. J. Biol. Chem. 279, 28257â28265 (2004).
Stroud, J. C. & Chen, L. Structure of NFAT bound to DNA as a monomer. J. Mol. Biol. 334, 1009â1022 (2003).
Macian, F., Lopez-Rodriguez, C. & Rao, A. Partners in transcription: NFAT and AP-1. Oncogene 20, 2476â2489 (2001).
Jain, J., McCaffrey, P. G., Valge-Archer, V. E. & Rao, A. Nuclear factor of activated T cells contains Fos and Jun. Nature 356, 801â804 (1992). This paper reports, for the first time, that the nuclear component that interacts with NFAT proteins in activated T cells is AP1.
Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37â40 (2001).
Macian, F., Garcia-Rodriguez, C. & Rao, A. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 19, 4783â4795 (2000).
Palacios, E. H. & Weiss, A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23, 7990â8000 (2004).
Wulfing, C., Sjaastad, M. D. & Davis, M. M. Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc. Natl Acad. Sci. USA 95, 6302â6307 (1998).
Perez, O. D. et al. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nature Immunol. 4, 1083â1092 (2003).
Acuto, O. & Michel, F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nature Rev. Immunol. 3, 939â951 (2003).
Diehn, M. et al. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl Acad. Sci. USA 99, 11796â11801 (2002).
Appleman, L. J., van Puijenbroek, A. A., Shu, K. M., Nadler, L. M. & Boussiotis, V. A. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J. Immunol. 168, 2729â2736 (2002).
Wang, D. et al. CD3/CD28 costimulation-induced NF-κB activation is mediated by recruitment of protein kinase C-q, Bcl10, and IκB kinase β to the immunological synapse through CARMA1. Mol. Cell. Biol. 24, 164â171 (2004).
Jun, J. E. et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18, 751â762 (2003).
Bodor, J. & Habener, J. F. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J. Biol. Chem. 273, 9544â9551 (1998).
Avni, O. et al. TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nature Immunol. 3, 643â651 (2002). This study shows that NFAT1 binds specifically to the Ifn-γ promoter in T H 1 cells and to the Il-4 promoter in T H 2 cells, where it cooperates with lineage-specific factors.
Decker, E. L. et al. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res. 31, 911â921 (2003).
Duncliffe, K. N., Bert, A. G., Vadas, M. A. & Cockerill, P. N. A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site. Immunity 6, 175â185 (1997).
Ho, I. C., Hodge, M. R., Rooney, J. W. & Glimcher, L. H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973â983 (1996).
Iacobelli, M., Wachsman, W. & McGuire, K. L. Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. J. Immunol. 165, 860â868 (2000).
Lee, D. U., Avni, O., Chen, L. & Rao, A. A distal enhancer in the interferon-γ (IFN-γ) locus revealed by genome sequence comparison. J. Biol. Chem. 279, 4802â4810 (2004).
Molkentin, J. D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215â228 (1998).
Rengarajan, J. et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003â1012 (2002).
Yang, T. T. & Chow, C. W. Transcription cooperation by NFATâ¢C/EBP composite enhancer complex. J. Biol. Chem. 278, 15874â15885 (2003).
Yang, X. Y. et al. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor γ (PPARγ) agonists. PPARγ co-association with transcription factor NFAT. J. Biol. Chem. 275, 4541â4544 (2000).
Youn, H. D., Chatila, T. A. & Liu, J. O. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19, 4323â4331 (2000).
Giffin, M. J. et al. Structure of NFAT1 bound as a dimer to the HIV-1 LTRκB element. Nature Struct. Biol. 10, 800â806 (2003).
Jin, L. et al. An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site. Nature Struct. Biol. 10, 807â811 (2003).
Chang, C. P. et al. A field of myocardialâendocardial NFAT signaling underlies heart valve morphogenesis. Cell 118, 649â663 (2004).
Muller, C. W. & Harrison, S. C. The structure of the NF-κB p50:DNA-complex: a starting point for analyzing the Rel family. FEBS Lett. 369, 113â117 (1995).
Timmerman, L. A. et al. Redundant expression but selective utilization of nuclear factor of activated T cells family members. J. Immunol. 159, 2735â2740 (1997).
Lyakh, L., Ghosh, P. & Rice, N. R. Expression of NFAT-family proteins in normal human T cells. Mol. Cell. Biol. 17, 2475â2484 (1997).
Chuvpilo, S. et al. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16, 881â895 (2002). This paper describes a property of NFAT2A, the only autoregulated NFAT isoform, in T cells.
Hodge, M. R. et al. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4, 397â405 (1996).
Xanthoudakis, S. et al. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272, 892â895 (1996).
Yoshida, H. et al. The transcription factor NF-ATc1 regulates lymphocyte proliferation and TH2 cytokine production. Immunity 8, 115â124 (1998).
Ranger, A. M. et al. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8, 125â134 (1998).
Starr, T. K., Jameson, S. C. & Hogquist, K. A. Positive and negative selection of T cells. Annu. Rev. Immunol. 21, 139â176 (2003).
von Boehmer, H. et al. Thymic selection revisited: how essential is it? Immunol. Rev. 191, 62â78 (2003).
Aifantis, I., Gounari, F., Scorrano, L., Borowski, C. & von Boehmer, H. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT. Nature Immunol. 2, 403â409 (2001).
Jenkins, M. K., Schwartz, R. H. & Pardoll, D. M. Effects of cyclosporine A on T cell development and clonal deletion. Science 241, 1655â1658 (1988).
Gao, E. K., Lo, D., Cheney, R., Kanagawa, O. & Sprent, J. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature 336, 176â179 (1988).
Bueno, O. F., Brandt, E. B., Rothenberg, M. E. & Molkentin, J. D. Defective T cell development and function in calcineurin Aβ-deficient mice. Proc. Natl Acad. Sci. USA 99, 9398â9403 (2002).
Neilson, J. R., Winslow, M. M., Hur, E. M. & Crabtree, G. R. Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity 20, 255â266 (2004).
Hayden-Martinez, K., Kane, L. P. & Hedrick, S. M. Effects of a constitutively active form of calcineurin on T cell activation and thymic selection. J. Immunol. 165, 3713â3721 (2000).
Oukka, M. et al. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 9, 295â304 (1998).
Amasaki, Y. et al. A constitutively nuclear form of NFATx shows efficient transactivation activity and induces differentiation of CD4+CD8+ T cells. J. Biol. Chem. 277, 25640â25648 (2002).
Amasaki, Y., Masuda, E. S., Imamura, R., Arai, K. & Arai, N. Distinct NFAT family proteins are involved in the nuclear NFATâDNA binding complexes from human thymocyte subsets. J. Immunol. 160, 2324â2333 (1998).
Ranger, A. M., Oukka, M., Rengarajan, J. & Glimcher, L. H. Inhibitory function of two NFAT family members in lymphoid homeostasis and TH2 development. Immunity 9, 627â635 (1998).
Rengarajan, J., Tang, B. & Glimcher, L. H. NFATc2 and NFATc3 regulate TH2 differentiation and modulate TCR-responsiveness of naive TH2 cells. Nature Immunol. 3, 48â54 (2002).
Schuh, K. et al. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur. J. Immunol. 28, 2456â2466 (1998).
Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933â944 (2002).
Agarwal, S. & Rao, A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9, 765â775 (1998).
Ansel, K. M., Lee, D. U. & Rao, A. An epigenetic view of helper T cell differentiation. Nature Immunol. 4, 616â623 (2003).
Szabo, S. J., Sullivan, B. M., Peng, S. L. & Glimcher, L. H. Molecular mechanisms regulating TH1 immune responses. Annu. Rev. Immunol. 21, 713â758 (2003).
Agarwal, S., Avni, O. & Rao, A. Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity 12, 643â652 (2000). This study identifies T H 2-cell-specific binding of NFAT1 to sites in the 3â² enhancer of the Il-4 gene.
Ansel, K. M. et al. Deletion of a conserved Il4 silencer impairs T helper type 1-mediated immunity. Nature Immunol. 5, 1251â1259 (2004).
Im, S. H., Hueber, A., Monticelli, S., Kang, K. H. & Rao, A. Chromatin-level regulation of the IL10 gene in T cells. J. Biol. Chem. 279, 46818â46825 (2004).
Kiani, A., Viola, J. P., Lichtman, A. H. & Rao, A. Down-regulation of IL-4 gene transcription and control of TH2 cell differentiation by a mechanism involving NFAT1. Immunity 7, 849â860 (1997).
Kiani, A. et al. Regulation of interferon-γ gene expression by nuclear factor of activated T cells. Blood 98, 1480â1488 (2001).
Monticelli, S. & Rao, A. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32, 2971â2978 (2002).
Porter, C. M. & Clipstone, N. A. Sustained NFAT signaling promotes a TH1-like pattern of gene expression in primary murine CD4+ T cells. J. Immunol. 168, 4936â4945 (2002).
Nurieva, R. I. et al. Transcriptional regulation of TH2 differentiation by inducible costimulator. Immunity 18, 801â811 (2003).
Riley, J. L. et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl Acad. Sci. USA 99, 11790â11795 (2002).
Teague, T. K. et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl Acad. Sci. USA 96, 12691â12696 (1999).
Feske, S., Draeger, R., Peter, H. H., Eichmann, K. & Rao, A. The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells. J. Immunol. 165, 297â305 (2000).
Peng, S. L., Gerth, A. J., Ranger, A. M. & Glimcher, L. H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14, 13â20 (2001). This study shows that NFAT1 and NFAT2 are necessary for T-cell activation and cytokine production.
Feske, S., Giltnane, J., Dolmetsch, R., Staudt, L. M. & Rao, A. Gene regulation mediated by calcium signals in T lymphocytes. Nature Immunol. 2, 316â324 (2001).
Baksh, S. et al. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol. Cell 10, 1071â1081 (2002).
Caetano, M. S. et al. NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J. 16, 1940â1942 (2002).
Macian, F., Im, S. H., Garcia-Cozar, F. J. & Rao, A. T-cell anergy. Curr. Opin. Immunol. 16, 209â216 (2004).
Schwartz, R. H. T cell anergy. Annu. Rev. Immunol. 21, 305â334 (2003).
Heissmeyer, V. et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nature Immunol. 5, 255â265 (2004).
Jeon, M. S. et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21, 167â177 (2004).
Seroogy, C. M. et al. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J. Immunol. 173, 79â85 (2004).
Anandasabapathy, N. et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18, 535â547 (2003).
Bopp, T. et al. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. J. Exp. Med. 201, 181â187 (2005).
Gremese, E. & Ferraccioli, G. F. Benefit/risk of cyclosporine in rheumatoid arthritis. Clin. Exp. Rheumatol. 22, S101âS107 (2004).
Ponticelli, C. et al. From cyclosporine to the future. Transplant. Proc. 36, 557Sâ560S (2004).
Kaufman, D. B. et al. Immunosuppression: practice and trends. Am. J. Transplant. 4, 38â53 (2004).
Griffiths, B. & Emery, P. The treatment of lupus with cyclosporin A. Lupus 10, 165â170 (2001).
Kiani, A., Rao, A. & Aramburu, J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12, 359â372 (2000).
Bechstein, W. O. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl. Int. 13, 313â326 (2000).
Olyaei, A. J., de Mattos, A. M. & Bennett, W. M. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr. Opin. Crit. Care 7, 384â389 (2001).
Noguchi, H. et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nature Med. 10, 305â309 (2004).
Li, H., Rao, A., Hogan. P. G. Structural delineation of the calcineurinâNFAT interactions and its parallels to PP1 targeting interactions. J. Mol. Biol. 342, 1659â1674 (2004).
Rodriguez, A., Martinez-Martinez, S., Lopez-Maderuelo, M. D., Ortega-Perez, I. & Redondo, J. M. The linker region joining the catalytic and the regulatory domains of CnA is essential for binding to NFAT. J. Biol. Chem. 280, 9980â9984 (2005).
Roehrl, M. H. et al. Selective inhibition of calcineurinâNFAT signaling by blocking proteinâprotein interaction with small organic molecules. Proc. Natl Acad. Sci. USA 101, 7554â7559 (2004).
Venkatesh, N. et al. Chemical genetics to identify NFAT inhibitors: potential of targeting calcium mobilization in immunosuppression. Proc. Natl Acad. Sci. USA 101, 8969â8974 (2004).
Acknowledgements
I thank A. M. Cuervo for critical reading of this manuscript. I give special thanks to A. Rao for stimulating discussions and many useful suggestions. I apologize to those colleagues whose work I could not cite owing to space limitations. This work was supported by grants from the National Institutes of Health (United States) and the Irene Diamond Fund (United States).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Glossary
- REL-FAMILY TRANSCRIPTION FACTORS
-
Also known as the nuclear factor-κB (NF-κB) family of transcription factors. These factors share an amino-terminal REL-homology domain that contains sequences that are responsible for nuclear localization, dimerization and DNA binding. Homo- or heterodimers of NF-κB proteins modulate the expression of genes that control immune, inflammatory and acute-phase responses, as well as cell growth, apoptosis and oncogenesis. In vertebrates, this family includes NF-κB1 (also known as p50), NF-κB2 (also known as p52), REL (also known as cREL), REL-A (also known as p65) and REL-B.
- TRANSACTIVATION DOMAIN
-
The domain of a transcription factor that binds the promoter region of a gene and induces its transcription.
- CALMODULIN
-
A small calcium-binding protein. Calmodulin is the most important transducer of intracellular calcium signals. It interacts with, and regulates the activity of, a range of proteins that control many cellular processes, including protein phosphorylation and dephosphorylation, cyclic-nucleotide formation and breakdown, cytoskeletal rearrangement, gene transcription and membrane potential.
- GREEN FLUORESCENT PROTEIN FUSION PROTEIN
-
(GFP fusion protein). A hybrid protein that is created by the fusion of the GFP from Aequorea victoria and another protein. This construct allows the tracking of the behaviour of the fused protein using the fluorescence that is emitted by GFP.
- SUMOYLATION
-
The post-translational modification of proteins that involves the covalent attachment of small ubiquitin-like modifier (SUMO) and regulates the interactions of those proteins with other macromolecules.
- NF-κB-BINDING MOTIF
-
(Nuclear factor-κB-binding motif). A DNA-binding sequence that is recognized by NF-κB proteins. Nuclear factor of activated T cells (NFAT)-dimer complexes can form on motifs that are similar to these.
- THYMIC INVOLUTION
-
An age-dependent decrease of thymic epithelial volume that results in the decreased production of T cells.
- T-BOX-FAMILY TRANSCRIPTION FACTORS
-
A family of transcription factors that contain a DNA-binding domain of 200 amino acids, which is known as the T box. These factors are usually involved in developmental programmes. The founding member of this family was Brachyury, and T-bet and eomesodermin are also members.
- CHROMATIN-REMODELLING COMPLEXES
-
Enzymatic complexes that achieve the remodelling of DNAânucleosomal architecture and determine transcriptional activity. The SWIâSNF (switching-defectiveâsucrose non-fermenting) ATPases are an example of complexes that remodel chromatin.
- HISTONE DEACETYLASE
-
An enzyme that removes the acetyl groups from lysine residues located at the amino termini of histones. In general, decreased levels of histone acetylation are associated with the repression of gene expression. The balance of histone acetylation is maintained by the interplay between histone deacetylases and histone acetyltransferases.
- ANERGY
-
A state of T cells that have been stimulated through their T-cell receptor in the absence of ligation of CD28. On restimulation, these T cells are unable to produce interleukin-2 or to proliferate, even in the presence of co-stimulatory signals.
- E3 UBIQUITIN LIGASE
-
An enzyme that attaches the molecular tag ubiquitin to proteins. Depending on the position and number of ubiquitin molecules that are attached, the ubiquitin tag can target proteins for degradation by the proteasomal complex, sort them to specific subcellular compartments or modify their biological activity.
- CD4+CD25+ REGULATORY T CELLS
-
(TReg cells). A specialized subset of CD4+ T cells that can suppress the responses of other T cells. These cells provide a crucial mechanism for the maintenance of peripheral self-tolerance, and they are characterized by the expression of the α-chain ofthe interleukin-2 receptor(also known as CD25) and the transcription factor FOXP3 (forkhead box P3).
- FLUORESCENCE-POLARIZATION ASSAY
-
A method that can be usedto evaluate the strength of a proteinâprotein interaction.A fluorescent tag is attachedto one of the protein partners. The formation of a complex is then deduced from an increase in fluorescence polarization, and the equilibrium dissociation constant of the complex can be determined.
Rights and permissions
About this article
Cite this article
Macian, F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5, 472â484 (2005). https://doi.org/10.1038/nri1632
Issue Date:
DOI: https://doi.org/10.1038/nri1632